Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2007; 28(03): 41-43
DOI: 10.1055/s-0041-1733229
Case Report

Multiple Myeloma Presenting with Hepatic Involvement

Amit Dhiman
Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, India
,
Lalit Bansal
Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, India
,
Jagdev Sekhon
Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, India
,
R. Ranga Rao
Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, India
,
Amarinder Sekhon
Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, India
,
Neeraj Prakash
Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
07 March 2022

© 2007. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kapadia SB. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore). 1980;59(5):380-92.
  • 2 Forester J, Paraskevas F. Multiple myeloma, In Lee GR, Foester J, Lukens J et al. (editors). Wintrobe’s clinical hematology. Pub. Williams & Wilkins, Maryland. 1999;10thedition p 2645.
  • 3 Nandedkar, Meenakshi A, Abbondanzo, et al. Extramedullary manifestation of multiple myeloma (systemic plasmacytoma) that simulates hemangioma: A report of 2 cases. Arch Pathol & Lab Med 2000;124:628-631.
  • 4 Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994;87(3):503-8.
  • 5 Vacca A, Ribatti D, Roncali L, et al. Angiogenesis in B-cell lymphoproliferative diseases: biological and clinical studies. Leuk Lymphoma 1995;20:27–38.
  • 6 Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999;59(3):728–733.
  • 7 Thiruvengadan R, Penetrante Rb. Multiple myeloma presenting as SOL of the liver. Cancer 1990;15(12):65.
  • 8 Perz-solar R, Esteban R. Liver involvement in multiple myeloma. Am J Hemetol 1985;20(1): 25-9.
  • 9 Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975;50(1):29-40.
  • 10 Park WK, Chang JC. A case of nodular hepatic involvement of Multiple Myeloma mimicking hypervascular hepatocellular carcinoma. Taehan Kan Hakhoe Chi 2002;8(4): 490.
  • 11 Anderson KC, Munshi NC. Plasma cell neoplasms, In Devita VT, Hellman S, Rosenberg SA (editors). Cancer, Principle and Practice of Oncology. Pub. Lippincott, Philadelphia. 2005;7thedition p 2165.
  • 12 Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998;152:1655
  • 13 Nozza A , Castagna L, Rahal D, et al. Massive liver involvement in a patient with multiple myeloma during Thalidomide treatment. Haema 2003;6(2):230- 232.